Agios Pharmaceuticals reported $0 in Current Assets for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acceleron Pharma XLRN:US $ 448M 16M
Alexion Pharmaceuticals ALXN:US $ 5367.9M 497.7M
Alnylam Pharmaceuticals ALNY:US $ 2554.7M 394.26M
Amgen AMGN:US $ 22895M 4082M
AstraZeneca AZN:LN 18.17B 3.24B
Bayer BAYN:GR 3.28B 24.6M
Biogen BIIB:US $ 7843.1M 650.7M
Biomarin Pharmaceutical BMRN:US $ 2647.57M 531.32M
Bluebird Bio BLUE:US $ 1613.44M 645.98M
Bristol Myers Squibb BMY:US $ 34343M 2490M
Daiichi Sankyo 4568:JP Y 1317804M 66315M
Eli Lilly And LLY:US $ 14581.9M 587.7M
Exelixis EXEL:US $ 1394M 258M
Gilead Sciences GILD:US $ 24643M 2307M
GlaxoSmithKline GSK:LN 2.3B 95.5M
Immunogen IMGN:US $ 219.33M 22.04M
JAZZ PHA JAZZ:US $ 2555.57M 253.23M
Merk MRK:US $ 29343M 3169M
Novartis NOVN:VX 23.88B 784M
Novartis NVS:US $ 28973M 5091M
Pfizer PFE:US $ 46424M 11686M
Puma Biotechnology PBYI:US $ 159M 1M
Regeneron Pharmaceuticals REGN:US $ 7860.2M 783.9M
Sarepta Therapeutics SRPT:US $ 2459M 88M
Seattle Genetics SGEN:US $ 2166.04M 835.46M
Vertex Pharmaceuticals VRTX:US $ 6694.32M 1247.92M
YTE INCY:US $ 2077.62M 361.46M